Skip to content
Blerp – Lifestyle
Author:
Retension Pharmaceuticals
Retension Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Corporate Update
November 18, 2026
Retension Pharmaceuticals to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
November 5, 2026
Retension Pharmaceuticals Announces Pricing of Initial Public Offering
October 8, 2026